[seoyoongchi]
Pharmaceutical Engineering · AI-driven discovery
MY AI LAB
Pharma Intelligence · Discovery · Deployment
Discovery stack
AI in Drug Discovery
From hypothesis to clinic—machine learning is reshaping how we discover, design, and deliver therapies.
Mission pulse
The Imperative of AI in Pharma
Traditional pharmaceutical R&D remains long-cycle and capital-intensive. Leading 2024–2025 industry analyses argue that computational AI is no longer optional—it is core infrastructure for sustainable pipelines.
Pipeline timeline
15
→
7
years (illustrative AI-accelerated target)
Cost per approval (indexed)
$2.6B
→
$1.5B
modeled reduction pathway (illustrative)
AI is not just an option, it is the new standard of saving lives.
Figures synthesize public-domain summaries (Tufts Center for the Study of Drug Development; IQVIA Institute; Deloitte; WHO R&D dialogues, 2024–2025). They are illustrative aggregates—not financial advice.